Changes in the mumps vaccine coverage and incidence of mumps before and after the public subsidization program: A descriptive study using a population-based database in Japan.

IF 3.8 3区 医学 Q2 INFECTIOUS DISEASES
So Sato,Sachiko Ono,Yusuke Sasabuchi,Kohei Uemura,Hideo Yasunaga
{"title":"Changes in the mumps vaccine coverage and incidence of mumps before and after the public subsidization program: A descriptive study using a population-based database in Japan.","authors":"So Sato,Sachiko Ono,Yusuke Sasabuchi,Kohei Uemura,Hideo Yasunaga","doi":"10.1016/j.ajic.2024.09.011","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nEvidence suggests that mumps infection can be eradicated by continuous mumps vaccine coverage. However, due to safety concerns, the mumps vaccination program in Japan shifted from routine to voluntary. To improve vaccination coverage rates, some municipalities began to independently provide subsidization programs for the mumps vaccine. However, the changes in vaccination coverage and incidence of mumps before and after initiating the subsidization programs remain unknown.\r\n\r\nMETHODS\r\nIn April 2018, a city in Japan started a subsidization program for the mumps vaccine for children aged 1-6 years. This study used data on vaccination records and healthcare claims from the city obtained between July 2016 and December 2019. We described changes in vaccination coverage, and the incidence of mumps infections before and after the start of the subsidization program.\r\n\r\nRESULTS\r\nThe mumps vaccination coverage rate among eligible children was 3.3% at the program's initiation; this increased by about 1.5% per month, reaching 38.4% 21 months after the initiation of the program. Among 308,976 individuals, 145 cases of mumps were identified; of these, 92 cases (0.27 cases per 1,000 person-years) occurred before, and 53 (0.15 cases per 1,000 person-years) occurred after the initiation of the subsidization program.\r\n\r\nCONCLUSION\r\nWhile the mumps vaccination coverage rate increased after the initiation of the subsidization program, it did not reach the level required for eradication.","PeriodicalId":7621,"journal":{"name":"American journal of infection control","volume":"6 1","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of infection control","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajic.2024.09.011","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND Evidence suggests that mumps infection can be eradicated by continuous mumps vaccine coverage. However, due to safety concerns, the mumps vaccination program in Japan shifted from routine to voluntary. To improve vaccination coverage rates, some municipalities began to independently provide subsidization programs for the mumps vaccine. However, the changes in vaccination coverage and incidence of mumps before and after initiating the subsidization programs remain unknown. METHODS In April 2018, a city in Japan started a subsidization program for the mumps vaccine for children aged 1-6 years. This study used data on vaccination records and healthcare claims from the city obtained between July 2016 and December 2019. We described changes in vaccination coverage, and the incidence of mumps infections before and after the start of the subsidization program. RESULTS The mumps vaccination coverage rate among eligible children was 3.3% at the program's initiation; this increased by about 1.5% per month, reaching 38.4% 21 months after the initiation of the program. Among 308,976 individuals, 145 cases of mumps were identified; of these, 92 cases (0.27 cases per 1,000 person-years) occurred before, and 53 (0.15 cases per 1,000 person-years) occurred after the initiation of the subsidization program. CONCLUSION While the mumps vaccination coverage rate increased after the initiation of the subsidization program, it did not reach the level required for eradication.
公共补贴计划前后腮腺炎疫苗覆盖率和腮腺炎发病率的变化:利用日本人口数据库进行的描述性研究。
背景有证据表明,持续接种流行性腮腺炎疫苗可以根除流行性腮腺炎感染。然而,出于安全考虑,日本的流行性腮腺炎疫苗接种计划从常规转为自愿。为了提高疫苗接种覆盖率,一些市镇开始独立提供流行性腮腺炎疫苗补贴计划。然而,在启动补贴计划前后,疫苗接种覆盖率和流行性腮腺炎发病率的变化仍是未知数。方法2018年4月,日本某市启动了针对1-6岁儿童的流行性腮腺炎疫苗补贴计划。本研究使用了该市在 2016 年 7 月至 2019 年 12 月期间获得的疫苗接种记录和医疗报销数据。结果在该计划启动时,符合条件的儿童腮腺炎疫苗接种覆盖率为 3.3%;该覆盖率每月增加约 1.5%,在计划启动 21 个月后达到 38.4%。在 308,976 人中发现了 145 例流行性腮腺炎病例;其中 92 例(每千人年 0.27 例)发生在补贴计划启动之前,53 例(每千人年 0.15 例)发生在补贴计划启动之后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.40
自引率
4.10%
发文量
479
审稿时长
24 days
期刊介绍: AJIC covers key topics and issues in infection control and epidemiology. Infection control professionals, including physicians, nurses, and epidemiologists, rely on AJIC for peer-reviewed articles covering clinical topics as well as original research. As the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信